Fennec Pharmaceuticals Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Fennec Pharmaceuticals Inc. (FENC) holds an ST Score of 70.9 out of 100 (B+), with its strongest factor being Profitability (A+) and its weakest Valuation (B-). Analysts rate FENC Buy across 8 ratings with a $16.00 average price target (+0.5% vs the current $10.62).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationB-
All factor grades
- ProfitabilityA+
- GrowthA
- MomentumB+
- Financial StrengthB
- ForecastB
- ValuationB-
- Piotroski5/9
Contact
FENC stock: frequently asked questions
What is FENC's ST Score?
Fennec Pharmaceuticals Inc. (FENC) has an ST Score of 70.9 out of 100, an overall grade of B+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is FENC a buy, sell, or hold?
Wall Street's consensus rating on FENC is Buy based on 8 analyst ratings. Our own ST Score grades it B+ (70.9/100). This is data, not investment advice — always do your own research.
What is FENC's valuation grade?
Fennec Pharmaceuticals Inc. (FENC) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is FENC's growth grade?
Fennec Pharmaceuticals Inc. (FENC) earns a growth grade of A, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is FENC's profitability grade?
Fennec Pharmaceuticals Inc. (FENC) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is FENC's financial strength grade?
Fennec Pharmaceuticals Inc. (FENC) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for FENC?
The average analyst price target for Fennec Pharmaceuticals Inc. (FENC) is $16.00 from 8 analysts, which is +0.5% versus the recent price of $10.62.
What is FENC's Piotroski score?
Fennec Pharmaceuticals Inc. (FENC) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.